TriStar Health Partners

TriStar Health Partners is an investment firm focused on pre-seed and seed stage healthcare innovation companies. It invests in life sciences, diagnostics, medical devices and technologies, IT, and healthcare companies. TriStar Health Partners was founded in 2009 and is based in Nashville, Tennessee.

Jacobson M.D., Harry R.

Managing Partner

Christopher Rand

Partner and Co-Founder

45 past transactions

TVA Medical

Series C in 2015
TVA Medical, Inc. (TVA) is a medical device company developing innovative, minimally invasive therapies for treatment of End-Stage Renal Disease (ESRD). The company is funded by Santé Ventures.

MedCenterDisplay

Series B in 2015
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Nusirt

Series C in 2015
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.

Evermind

Series A in 2015
Evermind provides peace of mind to individuals living alone and the people who care about them. In the old days, people lived in supporting communities, surrounded by family and friends who could look out for them by simply observing signs of their daily activities. Clothing hanging on a line or smoke rising from a chimney signaled that neighbors were safe and sound, without compromising their privacy. Evermind looks for modern-day signals of activity and well being by detecting when electrical appliances are switched on and off. With Evermind, daily rituals like making coffee in the morning or switching a bedside lamp off at night can serve as a simple check-in system, signaling that all is well without diminishing independence or requiring changes in routine.
Advanced Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters for endovascular debulking (clearing of blocked blood vessels).

MedCenterDisplay

Venture Round in 2014
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Molecular Sensing

Series A in 2014
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Octovis, Inc.

Seed Round in 2014
Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Preferral

Venture Round in 2014
Preferral is an referral management system. Preferral allows primary care practices save time on referrals, and specialists to increase and analyze their patient referrals. With Preferral's online referral forms, practices can add an easy-to-use referral form to their website. Patients can get referral appointments instantly while administrative costs are reduced and communications streamlined. Preferral doesn’t require any complicated integrations with the EHR. Preferral allows practices to uncover valuable insights about their referral relationships and improve marketing efforts. Preferral was founded by Jon Gautsch in 2013 and is headquartered in Nashville, Tennessee.

InvisionHeart

Series A in 2014
InvisionHeart draws on the strengths of experienced leadership, robust software and hardware developers and a strong clinical advisory team. The technology was originally developed by a team of physicians and engineers at Vanderbilt University in response to real-world clinical problems. Along with their team of investors, they share a vision for the improved care of heart patients wherever they live and work.

Octovis, Inc.

Seed Round in 2014
Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.

Bjond

Series A in 2014
Bjond Inc. operates in the technology sector. The company was founded in 2012 and is based in Columbus, Ohio. Bjönd is automated workflow, real-time decision support and behavior change software that consumers and businesses use to change outcomes and lives in any industry . . . in any situation. Bjönd is designed to enable anyone - even those with little or no technical skills - to build interactive content and automated, expert workflows for any subject.

GenomOncology

Venture Round in 2014
A venture backed and Cleveland, OH based healthcare technology company, GenomOncology is enabling precision medicine by transforming data into actionable information. We offer the GO Precision Medicine Portfolio - a suite of solutions that addresses the full range of needs for Healthcare Institutions. The portfolio supports technical assay validation and testing, clinical decision support, collaborative decision support for Molecular Tumor Board workflows and analytics for monitoring and discovery – to enable cancer precision medicine.

Molecular Sensing

Series A in 2013
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Quire

Seed Round in 2013
Quire gives you broad access to unstructured EMR notes, so you can search, filter, and visualize the data. It even takes into account details like a patient’s social and environmental factors. That way, you and your practice become deeply informed of your patients’ risk across your entire population.

Diagnovus

Seed Round in 2013
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

MedCenterDisplay

Series A in 2013
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

Preferral

Seed Round in 2013
Preferral is an referral management system. Preferral allows primary care practices save time on referrals, and specialists to increase and analyze their patient referrals. With Preferral's online referral forms, practices can add an easy-to-use referral form to their website. Patients can get referral appointments instantly while administrative costs are reduced and communications streamlined. Preferral doesn’t require any complicated integrations with the EHR. Preferral allows practices to uncover valuable insights about their referral relationships and improve marketing efforts. Preferral was founded by Jon Gautsch in 2013 and is headquartered in Nashville, Tennessee.

VenX Medical

Seed Round in 2013
VenX Medical LLC develops microvenous avulsion technology based prototype devices for the treatment of spider and reticular veins. It offers Nanophlebectomy, a hand held and disposable device, which is used to injure spider and reticular veins to disrupt the layers of the vein such that the vein coagulates; and VenX Reach, a minimally invasive device to perform horizontal phlebectomy, which treats a broad area of abnormal veins with minimal invasiveness. .

GOBA

Series A in 2013
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Molecular Sensing

Series A in 2013
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Diagnovus

Seed Round in 2013
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

TVA Medical

Series B in 2013
TVA Medical, Inc. (TVA) is a medical device company developing innovative, minimally invasive therapies for treatment of End-Stage Renal Disease (ESRD). The company is funded by Santé Ventures.

Quire

Seed Round in 2013
Quire gives you broad access to unstructured EMR notes, so you can search, filter, and visualize the data. It even takes into account details like a patient’s social and environmental factors. That way, you and your practice become deeply informed of your patients’ risk across your entire population.

Diagnovus

Seed Round in 2013
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Molecular Sensing

Seed Round in 2013
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Evermind

Seed Round in 2013
Evermind provides peace of mind to individuals living alone and the people who care about them. In the old days, people lived in supporting communities, surrounded by family and friends who could look out for them by simply observing signs of their daily activities. Clothing hanging on a line or smoke rising from a chimney signaled that neighbors were safe and sound, without compromising their privacy. Evermind looks for modern-day signals of activity and well being by detecting when electrical appliances are switched on and off. With Evermind, daily rituals like making coffee in the morning or switching a bedside lamp off at night can serve as a simple check-in system, signaling that all is well without diminishing independence or requiring changes in routine.

Cerebrotech Medical Systems

Venture Round in 2013
Cerebrotech has a novel technology for non-invasive monitoring of patients after stroke or traumatic brain injury. Current technologies for monitoring these patients are either invasive, are only snapshots, or don't tell the neurologist or intensivist what they really need to know about what is happening inside the brain. Cerebrotech has the solution.

GOBA

Seed Round in 2013
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diagnovus

Seed Round in 2013
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Pathfinder Technologies

Seed Round in 2013
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

Diagnovus

Seed Round in 2012
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

Molecular Sensing

Seed Round in 2012
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Pathfinder Technologies

Venture Round in 2012
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.

MedCenterDisplay

Seed Round in 2012
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walks through the door. Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider.

GOBA

Seed Round in 2012
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

Diabetes Care Group

Venture Round in 2012
Diabetes Care Group provides a highly specialized interdisciplinary model of care for individuals with diabetes. Their model integrates state-of-the-art medical management, patient education, and behavioral modification to improve patient self-management and clinical outcomes, while reducing the overall medical and social costs of diabetes. Their integrated approach, built on more than ten years of research and clinical experience, has a track record of getting results for individuals with diabetes. Their program offers an innovative, interdisciplinary approach to diabetes care that has delivered significant, sustained, and documented improvements in outcomes among the most challenging diabetes patients. At Diabetes Care Group, an experienced team, including board certified physicians, registered nurse educators, registered dieticians, and medical assistants, is dedicated to improving your health and quality of life.

Cerebrotech Medical Systems

Venture Round in 2012
Cerebrotech has a novel technology for non-invasive monitoring of patients after stroke or traumatic brain injury. Current technologies for monitoring these patients are either invasive, are only snapshots, or don't tell the neurologist or intensivist what they really need to know about what is happening inside the brain. Cerebrotech has the solution.

Molecular Sensing

Seed Round in 2012
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Diabetes Care Group

Seed Round in 2012
Diabetes Care Group provides a highly specialized interdisciplinary model of care for individuals with diabetes. Their model integrates state-of-the-art medical management, patient education, and behavioral modification to improve patient self-management and clinical outcomes, while reducing the overall medical and social costs of diabetes. Their integrated approach, built on more than ten years of research and clinical experience, has a track record of getting results for individuals with diabetes. Their program offers an innovative, interdisciplinary approach to diabetes care that has delivered significant, sustained, and documented improvements in outcomes among the most challenging diabetes patients. At Diabetes Care Group, an experienced team, including board certified physicians, registered nurse educators, registered dieticians, and medical assistants, is dedicated to improving your health and quality of life.

ONFocus Healthcare

Venture Round in 2012
Originally founded in 1985 as a healthcare strategic planning consulting firm called m21partners, onFocus Healthcare was re-incorporated in 2008 as a business execution software solutions company. Today, onFocus is the leading provider of enterprise performance management (EPM) software and support services for the healthcare marketplace. Their product, onFocus epm™, ensures that patients get better, faster, and less expensive care by helping hospitals continuously execute and perform at higher levels. They are dedicated to the success of healthcare organizations and the executives, managers and employees who lead them. Through the use of their software products and advisory services, they strive to improve the execution success and performance of every provider they work with by at least 20%.

Molecular Sensing

Venture Round in 2011
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering

Diagnovus

Seed Round in 2011
Founded in 2011 and based in Nashville, TN, Diagnovus’s mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects. Their core principles are defined by a passion to serve and dedication to create evidence-based molecular diagnostic products. By employing these values and principles, they believe they will make a meaningful contribution to improving outcomes for patients, help physicians to provide more effective care and contribute to a more efficient use of health care resources.

GOBA

Seed Round in 2010
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.

ONFocus Healthcare

Series B in 2010
Originally founded in 1985 as a healthcare strategic planning consulting firm called m21partners, onFocus Healthcare was re-incorporated in 2008 as a business execution software solutions company. Today, onFocus is the leading provider of enterprise performance management (EPM) software and support services for the healthcare marketplace. Their product, onFocus epm™, ensures that patients get better, faster, and less expensive care by helping hospitals continuously execute and perform at higher levels. They are dedicated to the success of healthcare organizations and the executives, managers and employees who lead them. Through the use of their software products and advisory services, they strive to improve the execution success and performance of every provider they work with by at least 20%.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.